![](/img/cover-not-exists.png)
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer
Renouf, D. J., Hedley, D., Krzyzanowska, M. K., Schmuck, M., Wang, L., Moore, M. J.Volume:
78
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3102-y
Date:
September, 2016
File:
PDF, 438 KB
english, 2016